CytImmune Sciences seeking to raise $2 million for a phase 2 trial of pancreatic cancer therapy – Baltimore Business Journal

{iframe}https://www.bizjournals.com/baltimore/news/2017/10/23/rockville-based-cancer-therapy-company-cytimmune.html{/iframe}